Study guide

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications

Key Takeaways Explain This Topic AI

Acute alcohol intoxication decreases anesthetic requirement through additive CNS depression, whereas chronic use in a currently sober patient increases MAC through enzyme induction and cross-tolerance.

Delirium tremens appears 48 to 96 hours after the last drink with a globally clouded sensorium and carries 5 to 15 percent mortality, while alcoholic hallucinosis occurs earlier with an intact sensorium.

Benzodiazepines are the only agents proven to reduce seizures and mortality in alcohol withdrawal; dexmedetomidine controls autonomic signs but does not prevent seizures and cannot substitute.

Pure beta-blockers are avoided in cocaine toxicity because unopposed alpha stimulation worsens hypertension and coronary vasospasm; benzodiazepines are first-line, followed by nitroglycerin and phentolamine.

Chronic cocaine and methamphetamine use depletes presynaptic catecholamine stores, so indirect sympathomimetics such as ephedrine may fail and direct-acting vasopressors are required.

Last updated: August 2026

Why This Topic Matters on the NCE

Domain IV.B.5 of the content outline is the substance use disorder population , with four sub-topics: medication-assisted therapy, pharmacologic interactions including acute intoxication, pain management, and management of complications. Medication-assisted therapy and pain management are covered in the chronic pain chapter. This section covers acute intoxication and withdrawal — the situations where the drug in the patient's system right now changes the anesthetic.

  • 1. Alcohol
  • The MAC paradox

State Effect on anesthetic requirement Mechanism

Acute intoxication Decreased MAC and decreased induction dose requirement Additive central nervous system depression

Chronic use, currently sober Increased MAC and increased requirement Hepatic enzyme induction plus central cross-tolerance

Getting these backwards is one of the most common errors on this topic. The acutely intoxicated trauma patient needs less anesthetic; the chronic drinker who arrives sober needs more .

  • Systemic consequences of chronic use
  • Alcoholic cardiomyopathy with reduced ejection fraction, and alcohol-related atrial fibrillation

Cirrhosis with coagulopathy, thrombocytopenia, hypoalbuminemia, ascites, esophageal varices, encephalopathy, and altered drug metabolism

  • Malnutrition : thiamine, folate, magnesium, and phosphate deficiency
  • Peripheral neuropathy — document it before any regional technique

Increased perioperative infection, bleeding, and cardiopulmonary complication rates ; even 4 weeks of preoperative abstinence measurably reduces complications

Alcohol withdrawal: a timeline you must know

  • Time after last drink Syndrome
  • 6 to 24 hours Minor withdrawal: tremor, anxiety, diaphoresis, tachycardia, hypertension, nausea
  • 12 to 48 hours Alcoholic hallucinosis — hallucinations with an intact sensorium and normal vital signs
  • 6 to 48 hours Withdrawal seizures — generalized tonic-clonic, usually brief and self-limited

48 to 96 hours Delirium tremens — clouded sensorium, disorientation, agitation, severe autonomic hyperactivity, fever

Delirium tremens carries a mortality of roughly 5 to 15 percent with treatment, and historically up to about 20 percent untreated. The distinguishing feature from alcoholic hallucinosis is the globally altered sensorium — a patient with hallucinosis knows where they are.

Treatment

Benzodiazepines are first-line and are the only agents shown to reduce seizures and mortality. Symptom-triggered dosing guided by a CIWA-Ar score is preferred to fixed schedules. Lorazepam is favored in hepatic impairment because it lacks active metabolites.

Dexmedetomidine is an adjunct only. It controls autonomic hyperactivity and agitation but does not prevent seizures and must never replace benzodiazepines.

Phenobarbital is an alternative or adjunct in benzodiazepine-refractory withdrawal.

Thiamine must be given before any glucose-containing fluid to prevent precipitating Wernicke encephalopathy (the triad of ophthalmoplegia, ataxia, and confusion) in a thiamine-depleted patient. Add folate, magnesium, and phosphate.

Beta-blockers and clonidine mask the autonomic signs without treating the underlying process; they are adjuncts at most.

  • 2. Cocaine
  • Acute intoxication

Cocaine blocks presynaptic reuptake of norepinephrine, dopamine, and serotonin, producing a sympathomimetic state: hypertension, tachycardia, coronary vasospasm , dysrhythmias, hyperthermia, agitation, seizures, and a genuine risk of myocardial infarction and aortic dissection in young patients with normal coronary arteries.

Delay elective surgery in an acutely intoxicated patient. Cocaine has a short plasma half-life of roughly 45 to 90 minutes, but its metabolites and clinical effects persist far longer, and a urine screen remains positive for days.

The management rule

Do not give a pure beta-blocker. Beta-blockade in the presence of high circulating catecholamines leaves unopposed alpha stimulation , worsening hypertension and coronary vasospasm. The management order is:

Benzodiazepines first — they reduce central sympathetic outflow and treat agitation, hypertension, tachycardia, and seizure risk simultaneously

  • Nitroglycerin for coronary vasospasm and hypertension
  • Phentolamine (alpha-blocker) for refractory hypertension
  • Calcium channel blockers such as nicardipine
  • Aggressive cooling for hyperthermia

Labetalol has combined alpha and beta blockade but its beta effect predominates roughly seven to one, so it is not a satisfactory substitute for a pure alpha-blocker in this setting.

Chronic use

Chronic cocaine and methamphetamine use depletes presynaptic catecholamine stores . The clinical consequence is that indirect-acting sympathomimetics such as ephedrine may fail , and refractory intraoperative hypotension should be treated with direct-acting agents — phenylephrine, norepinephrine, and vasopressin. Chronic users also have cardiomyopathy, accelerated atherosclerosis, and, with nasal use, septal perforation that complicates nasal instrumentation.

3. Methamphetamine and Other Stimulants

The same principles as cocaine, with a longer duration of action (plasma half-life of roughly 10 to 12 hours). Chronic methamphetamine use adds severe dental disease complicating airway management and intubation, cardiomyopathy, pulmonary hypertension, malnutrition, and psychosis. Refractory hypotension from catecholamine depletion is common and responds to direct-acting vasopressors and vasopressin.

  • 4. Opioids
  • Withdrawal

Opioid withdrawal in an adult is intensely unpleasant but not usually life threatening , which distinguishes it from alcohol, benzodiazepine, and barbiturate withdrawal.

Features: mydriasis, lacrimation, rhinorrhea, yawning, piloerection, diaphoresis, myalgias, abdominal cramping, diarrhea, vomiting, restlessness, and hypertension with tachycardia. Severity is scored with the COWS scale.

Two important exceptions:

Neonatal abstinence syndrome in the infant of an opioid-dependent mother is life threatening , with seizures and feeding failure.

Withdrawal in a critically ill patient can precipitate cardiovascular decompensation.

Precipitated withdrawal — from naloxone, or from giving nalbuphine, butorphanol, or buprenorphine to a full-agonist-dependent patient — is far more severe and abrupt than spontaneous withdrawal.

Overdose

Miosis, respiratory depression with a reduced rate, and depressed consciousness. Naloxone is titrated in small increments (40 to 80 mcg) in the postoperative setting to restore ventilation without abolishing analgesia and precipitating a hypertensive, tachycardic, agonizing withdrawal state that has caused pulmonary edema. Naloxone's duration is shorter than that of most opioids, so re-sedation is the predictable danger and an infusion or repeated dosing with continued monitoring is required.

5. Sedative-Hypnotic Withdrawal

Benzodiazepine and barbiturate withdrawal are life threatening , producing seizures, delirium, and autonomic instability much like alcohol withdrawal, because all three act on the GABA-A receptor complex. Chronic benzodiazepine therapy should be continued perioperatively or covered with an equivalent, never abruptly stopped. The same reasoning applies to the herbal GABAergic valerian.

6. Nicotine and Tobacco

The time course of benefit from cessation is directly testable:

Time after cessation Benefit

12 to 24 hours Carboxyhemoglobin falls toward normal (half-life 4 to 6 hours breathing air), improving oxygen-carrying capacity; nicotine cleared, reducing myocardial oxygen demand

  • 48 to 72 hours Ciliary function begins to recover; carboxyhemoglobin normalized
  • 1 to 2 weeks Sputum volume paradoxically increases as clearance improves
  • 4 to 6 weeks Reduction in postoperative pulmonary complications begins to be measurable
  • 8 weeks or more Maximal reduction in pulmonary complications

The nuance worth knowing is that the large pulmonary benefit requires weeks , while the carboxyhemoglobin and nicotine benefit appears within a day — so even overnight abstinence is worthwhile and should be encouraged, and there is no evidence that brief preoperative cessation increases complications.

Exam Traps

Acute alcohol lowers MAC; chronic alcohol raises it.

Delirium tremens is at 48 to 96 hours; hallucinosis is earlier and has an intact sensorium.

Benzodiazepines are first-line for both alcohol withdrawal and cocaine toxicity. Dexmedetomidine does not prevent seizures.

Thiamine before glucose.

No pure beta-blocker after cocaine — unopposed alpha.

Chronic stimulant use depletes catecholamines — use direct-acting vasopressors.

Loading diagram... Alcohol Withdrawal Timeline After the Last Drink